Carrie is a seasoned healthcare law, biosciences, and antitrust attorney. In her healthcare law and biosciences practice, she assists healthcare systems, surgical centers, physician groups, long–term care facilities, hospices, home health providers, and entities engaged in the clinical research across the State of North Carolina and beyond. Carrie’s antitrust experience covers a variety of industries with a particular focus on healthcare antitrust matters.
Carrie routinely counsels healthcare clients on licensure and certification, enrollment and reimbursement, accreditation, certificate of need, regulatory and compliance issues, and medical staff matters. Carrie has significant arbitration and trial experience, appearing in both state and federal courts as well as in administrative proceedings. Because of her experience and acumen, she has been selected to serve as a member of the board of directors of the North Carolina Society of Health Care Attorneys, and she has broad connections within the industry.
Carrie prepares and negotiates clinical trial agreements, confidentiality agreements, investigator–initiated study agreements, material transfer agreements, and grant funding agreements. She advises clients on compliance matters related to human subject protection, including the Common Rule, the Health Insurance Portability and Accountability Act of 1996, and other privacy matters, as well as site and investigator obligations and Institutional Review Board responsibilities.
Carrie assists clients with a variety of antitrust matters. She advises clients on pricing, distribution, mergers and acquisitions, joint ventures, and Hart–Scott–Rodino premerger notification filings. Though she works with clients in a variety of industries, she has a particular focus on healthcare antitrust matters.
Carrie has also worked in a pro bono capacity representing North Carolina’s abused, neglected, and dependent children in the capacity of an appellate guardian ad litem attorney advocate since 2006.
More Legal and Business Bylines From Carrie A. Hanger
- The 2023 Merger Guidelines Signal Continued Vigorous Antitrust Enforcement - (Posted On Friday, May 10, 2024)
- What the FTC’s Rule Banning Non-Competes Means for Healthcare - (Posted On Wednesday, April 24, 2024)
- FTC Increases the HSR Reporting Thresholds, Filing Fees and Thresholds, and Maximum Civil Penalties for 2024 - (Posted On Wednesday, January 24, 2024)
- Antitrust Enforcement Agencies Extend Comment Deadline on Proposed HSR Changes - (Posted On Wednesday, August 09, 2023)
- North Carolina Health Planning Update for 2024: Summer Petitions Have Been Filed - (Posted On Tuesday, August 01, 2023)
- Federal Trade Commission Proposes Major Changes to Hart-Scott-Rodino Process - (Posted On Friday, July 28, 2023)
- The Other Shoe Drops: What the FTC’s Withdrawal of Long-Standing Antitrust Guidance in the Healthcare Industry and the Demise of its Information Sharing Safety Zone Really Means for Clients - (Posted On Friday, July 28, 2023)
- Avoiding Antitrust Traps for the Unwary: Guardrails for Healthcare Transactions [Podcast] - (Posted On Thursday, July 27, 2023)
- The Proposed 2024 SMFP Has Arrived - Petitions to Adjust Need Determinations Are Due Soon! - (Posted On Wednesday, July 05, 2023)
- If Enacted, North Carolina House Bill 737 Will Transform the Legal Landscape for Hospital Transactions - (Posted On Thursday, April 27, 2023)